Bristol-Myers Squibb Aktie
55,54
EUR
+0,18
EUR
+0,33
%
60,53
USD
±0,00
USD
±0,00
%
Werbung
Bristol-Myers Squibb Aktie Analyse
| 05.05.17 | Bristol-Myers Squibb Underperform | BMO Capital Markets | |
| 27.10.14 | Bristol-Myers Squibb Sell | MKM Partners | |
| 25.01.08 | Bristol-Myers Squibb sell | Goldman Sachs Group Inc. | |
| 05.09.07 | Bristol-Myers Squibb sell | Goldman Sachs Group Inc. | |
| 28.09.06 | Bristol-Myers Squibb verkaufen | Wertpapier | |
| 09.08.06 | Bristol-Myers Squibb sell | A.G. Edwards & Sons | |
| 14.10.05 | Bristol-Myers Squibb reduce | Jyske Bank | |
| 29.07.05 | Bristol-Myers Squibb reduce | Jyske Bank | |
|
Werbung
|
|||
| 15.07.05 | Bristol-Myers Squibb reduce | Jyske Bank | |
| 17.06.05 | Bristol-Myers Squibb reduce | Jyske Bank | |
| 23.05.05 | Bristol-Myers Squibb underweight | Prudential Financial | |
| 23.05.05 | Bristol-Myers Squibb underweight | Prudential Financial | |
| 21.03.05 | Bristol-Myers Squibb Underweight | JP Morgan | |
Werbung
Werbung